Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel With Rapid Hormonal Cycling in Prostate Cancer
NCT00587431Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2003
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of docetaxel in prostate cancer (PCa) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Prostate-Specific Antigen Response at 18 months. Started Jul 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00587431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587431.